Investigational Site Number : 7240007

Madrid, Madrid, Comunidad de 28046

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Plasma Cell Myeloma Recurrent

Studies at this site

• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) — Completed